Novartis to spin off Alcon, will buy back $5 billion in shares

ZURICH (Reuters) - Novartis unveiled its long-expected plan to spin off all of its Alcon eye care devices business and launch a share buyback of up to $5 billion as the company sharpens its focus on prescription drugs, it said on Friday.

from Reuters: Business News https://ift.tt/2ICSTI3